Chongqing Zhifei Biological Products Co., Ltd.
Shenzhen Stock Exchange 300122.SZ
Chongqing Zhifei Biological Products Co., Ltd. Gross Profit for the year ending December 31, 2023: USD 2.01 B
Chongqing Zhifei Biological Products Co., Ltd. Gross Profit is USD 2.01 B for the year ending December 31, 2023, a 7.58% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
-
Chongqing Zhifei Biological Products Co., Ltd. Gross Profit for the year ending December 31, 2022 was USD 1.86 B, a -21.17% change year over year.
-
Chongqing Zhifei Biological Products Co., Ltd. Gross Profit for the year ending December 31, 2021 was USD 2.37 B, a 160.72% change year over year.
-
Chongqing Zhifei Biological Products Co., Ltd. Gross Profit for the year ending December 31, 2020 was USD 907.31 M, a 41.94% change year over year.
-
Chongqing Zhifei Biological Products Co., Ltd. Gross Profit for the year ending December 31, 2019 was USD 639.24 M, a 53.54% change year over year.
Key data
| Date | Gross Profit | Operating Income | EBIT | EBITDA |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 300122.SZ
| CEO | Mr. Rensheng Jiang |
| IPO Date | Sept. 28, 2010 |
| Location | China |
| Headquarters | No. 7 Jinyuan Road |
| Employees | 6,545 |
| Sector | Health Care |
| Industries | |
Description
Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, and marketing of vaccines and biological products in China. The company was founded in 2009 and is based in Chongqing, China.
Key trends
Past 5 years
Similar companies
Walvax Biotechnology Co., Ltd.
USD 1.59
4.31%
Aier Eye Hospital Group Co., Ltd.
USD 1.73
3.02%
Hualan Biological Engineering Inc.
USD 2.17
2.25%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
USD 32.18
1.97%
Changchun High-Tech Industries (Group) Inc.
USD 12.91
2.15%
StockViz Staff
January 15, 2025
Any question? Send us an email